Chen Yu, Bao Yi, Zhang Jingping, Woehrle Tobias, Sumi Yuka, Ledderose Stephan, Li Xiaoou, Ledderose Carola, Junger Wolfgang G
*Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and the †Ludwig Boltzmann Institute for Traumatology, Vienna, Austria.
Shock. 2015 Sep;44(3):221-7. doi: 10.1097/SHK.0000000000000402.
Hypertonic saline (HS) resuscitation has been studied as a possible strategy to reduce polymorphonuclear neutrophil (PMN) activation and tissue damage in trauma patients. Hypertonic saline blocks PMNs by adenosine triphosphate (ATP) release and stimulation of A2a adenosine receptors. Here, we studied the underlying mechanisms in search of possible reasons for the inconsistent results of recent clinical trials with HS resuscitation. Purified human PMNs or PMNs in whole blood were treated with HS to simulate hypertonicity levels found after HS resuscitation (40 mmol/L beyond isotonic levels). Adenosine triphosphate release was measured with a luciferase assay. Polymorphonuclear neutrophil activation was assessed by measuring oxidative burst. The pannexin-1 (panx1) inhibitor panx1 and the gap junction inhibitor carbenoxolone (CBX) blocked ATP release from PMNs in purified and whole blood preparations, indicating that HS releases ATP via panx1 and gap junction channels. Hypertonic saline blocked N-formyl-Met-Leu-Phe-induced PMN activation by 40% in purified PMN preparations and by 60% in whole blood. These inhibitory effects were abolished by panx1 but only partially reduced by CBX, which indicates that panx1 has a central role in the immunomodulatory effects of HS. Inhibition of the ectonucleotidases CD39 and CD73 abolished the suppressive effect of HS on purified PMN cultures but only partially reduced the effect of HS in whole blood. These findings suggest redundant mechanisms in whole blood that may strengthen the immunomodulatory effect of HS in vivo. We conclude that HS resuscitation exerts anti-inflammatory effects that involve panx1, CD39, CD73, and other ectonucleotidases, which produce the adenosine that blocks PMNs by stimulating their A2a receptors. Our findings shed new light on the immunomodulatory mechanisms of HS and suggest possible new strategies to improve the clinical efficacy of hypertonic resuscitation.
高渗盐水(HS)复苏已被研究作为一种可能的策略,以减少创伤患者多形核中性粒细胞(PMN)的激活和组织损伤。高渗盐水通过三磷酸腺苷(ATP)释放和刺激A2a腺苷受体来阻断PMN。在此,我们研究了潜在机制,以寻找近期HS复苏临床试验结果不一致的可能原因。用HS处理纯化的人PMN或全血中的PMN,以模拟HS复苏后发现的高渗水平(比等渗水平高40 mmol/L)。用荧光素酶测定法测量ATP释放。通过测量氧化爆发评估PMN激活。泛连接蛋白-1(panx1)抑制剂panx1和缝隙连接抑制剂卡本氧酮(CBX)阻断了纯化和全血制剂中PMN的ATP释放,表明HS通过panx1和缝隙连接通道释放ATP。在纯化的PMN制剂中,高渗盐水使N-甲酰甲硫氨酸-亮氨酸-苯丙氨酸诱导的PMN激活降低40%,在全血中降低60%。这些抑制作用被panx1消除,但仅被CBX部分降低,这表明panx1在HS的免疫调节作用中起核心作用。抑制外核苷酸酶CD39和CD73消除了HS对纯化PMN培养物的抑制作用,但仅部分降低了HS在全血中的作用。这些发现表明全血中存在冗余机制,可能会增强HS在体内的免疫调节作用。我们得出结论,HS复苏发挥抗炎作用,涉及panx1、CD39、CD73和其他外核苷酸酶,它们产生腺苷,通过刺激A2a受体来阻断PMN。我们的发现为HS的免疫调节机制提供了新的见解,并提出了可能提高高渗复苏临床疗效的新策略。